How GSSI, A Nonprofit, is Fighting Gastroparesis

Video

Patrick Dunegan, Rare Impact Awardee, explains how GSSSI, a 501c3 nonprofit organization, is working to fight gastroparesis, a gastric motility disorder known to be very debilitating for those who suffer from it.

Patrick Dunegan, Rare Impact Awardee, Kentucky colonel and executive director of Gastroparesis Support Services, Inc., explains how GSSSI, a 501c3 nonprofit organization, is working to fight gastroparesis, a gastric motility disorder known to be very debilitating for those who suffer from it.

Dunegan: Gastroparesis Support Services Inc. is dedicated to taking care of patients and families who travel to Louisville, Kentucky, for a GI test and surgeries. It’s basically modeled after the Ronald McDonald house, but it’s just for gastroparesis, and we're referred to by the U of L GI Motility Clinic only, that way we take care of those patients. The last thing we want them to worry about when they’re coming into the big city of Louisville, Kentucky, is their stay and their family; we want them to concentrate on their condition, and that’s what brought us to where we’re at now. Originally, it was called Jennifer’s GP House, and since we don’t have a facility to actually house people in, we decided we would call it Gastroparesis Support Services, and supplement hotels, Uber lifts, food voucher cards from restaurants so that takes care of that until we actually get a facility.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.